Heyholder
‹ Activism Filings

Polaris AI Pharma Corp. Q3 profit from the main business KRW 52.6 million, down 96.7% from a year earlier

Polaris AI Pharma Corp.· Periodic Report

AI summary · Not investment advice

Polaris AI Pharma sold KRW 11.9 billion in Q3 and earned KRW 52.6 million from its main business, down 96.7% from a year earlier and 93.2% from the prior quarter.

Operating profit · 3 months

KRW 52.6 million

Key facts

Revenue (3 months)
KRW 11.9 billion
Net income (3 months)
KRW -332.8 million
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 14.7 billion
Revenue (year to date)
KRW 40.3 billion
Operating profit (prior-year 3 months)
KRW 1.6 billion
Operating profit (year to date)
KRW 1.4 billion
Net income (prior-year 3 months)
KRW 3.5 billion
Net income (year to date)
KRW 10.1 billion

Commentary

AI commentary · Not investment advice

What happened

Polaris AI Pharma reported its standalone results for the third quarter of 2026. Sales for the 3 months were KRW 11.94 billion. That is 18.8% lower than the same 3 months a year earlier, and also 18.8% lower than the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was KRW 52.6 million. That is 96.7% lower than a year earlier and 93.2% lower than the previous quarter. Net income for the 3 months was a loss of KRW 332.8 million. A year earlier, the company had net income of KRW 3.50 billion, so it has swung to a loss. It also swung to a loss compared with the previous quarter.

What changes for shareholders

For the year to date (January 1 to September 30), sales were KRW 40.35 billion. Operating profit was KRW 1.44 billion. Net income was KRW 10.07 billion.

Comments

No comments yet

Comments from shareholders will appear here.